PRKAA2 and metabolic dysfunction-associated steatotic liver disease: Notably, compensatory upregulation of the KISS1 (Kisspeptin 1)/KISS1R (KISS1 Receptor) system and cardiotrophin-1 (CT-1) may partially counteract the overall decrease in AMPK activity in MASLD by promoting AMPK activation (33).